As of June 06, 2026, Aquestive Therapeutics's top three insider holders are Alexander Mark Schobel (Chief Innovation/Tech Officer, 984.48K shares), Keith J Kendall (Ceo And President, 637.15K shares), Lori J Braender (Chief Legal Officer, 442.88K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| A Ernest Jr Toth | Chief Financial Officer | 376,112 | 0 | 11 Mar, 2026 |
| Keith J Kendall | Ceo And President | 636,149 | 1,000 | 27 Aug, 2021 |
| Alexander Mark Schobel | Chief Innovation/Tech Officer | 984,476 | 0 | 19 Mar, 2024 |
| Ken W. Marshall | Svp, Chief Commercial Officer | 150,000 | 0 | 09 Mar, 2023 |
| Lori J Braender | Chief Legal Officer | 442,879 | 0 | 11 Mar, 2026 |
| Carl N Kraus | Chief Medical Officer | 282,475 | 0 | 16 Oct, 2025 |
| Stephen Wargacki | Chief Science Officer | 343,552 | 0 | 11 Mar, 2025 |
| Sherry Korczynski | Chief Commercial Officer | 241,117 | 0 | 11 Mar, 2026 |
| Melina Cioffi | Svp, Regulatory Affairs | 274,867 | 0 | 11 Mar, 2026 |
| Matthew W. Davis | Chief Development Officer | 100,000 | 0 | 11 Mar, 2026 |
| Matthew J. Greenhawt | Chief Medical Officer | 75,000 | 0 | 11 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Mar, 2026 | Melina Cioffi | Common Stock | A | 100,000 | $0.00 | 300,178 | D | A |
| 09 Mar, 2026 | Matthew W. Davis | Common Stock | A | 50,000 | $0.00 | 100,000 | D | A |
| 09 Mar, 2026 | Matthew W. Davis | Common Stock | A | 50,000 | $0.00 | 100,000 | D | A |
| 09 Mar, 2026 | A Ernest Jr Toth | Common Stock | A | 95,000 | $0.00 | 434,366 | D | A |
| 09 Mar, 2026 | Sherry Korczynski | Common Stock | A | 75,000 | $0.00 | 256,858 | D | A |
| 09 Mar, 2026 | A Ernest Jr Toth | Common Stock | A | 95,000 | $0.00 | 434,366 | D | A |
| 09 Mar, 2026 | Melina Cioffi | Common Stock | A | 100,000 | $0.00 | 300,178 | D | A |
| 09 Mar, 2026 | Sherry Korczynski | Common Stock | A | 75,000 | $0.00 | 256,858 | D | A |
| 09 Mar, 2026 | Lori J Braender | Common Stock | A | 80,000 | $0.00 | 482,981 | D | A |
| 09 Mar, 2026 | Lori J Braender | Common Stock | A | 80,000 | $0.00 | 482,981 | D | A |
| 09 Mar, 2026 | Melina Cioffi | Common Stock | A | 100,000 | $0.00 | 300,178 | D | A |
| 09 Mar, 2026 | Matthew W. Davis | Common Stock | A | 50,000 | $0.00 | 100,000 | D | A |
| 09 Mar, 2026 | Sherry Korczynski | Common Stock | A | 75,000 | $0.00 | 256,858 | D | A |
| 09 Mar, 2026 | A Ernest Jr Toth | Common Stock | A | 95,000 | $0.00 | 434,366 | D | A |
| 09 Mar, 2026 | Lori J Braender | Common Stock | A | 80,000 | $0.00 | 482,981 | D | A |
| 10 Mar, 2026 | Sherry Korczynski | Common Stock | D | 15,741 | $4.17 | 241,117 | D | S |
| 10 Mar, 2026 | Lori J Braender | Common Stock | D | 40,102 | $4.17 | 442,879 | D | S |
| 09 Mar, 2026 | Matthew W. Davis | Non-Qualified Stock Option (right to buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 10 Mar, 2026 | Melina Cioffi | Common Stock | D | 25,311 | $4.17 | 274,867 | D | S |
| 10 Mar, 2026 | Lori J Braender | Common Stock | D | 40,102 | $4.17 | 442,879 | D | S |